Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 May;80(5):469-74.
doi: 10.1111/j.1349-7006.1989.tb02338.x.

Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line

Affiliations

Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line

I Sugawara et al. Jpn J Cancer Res. 1989 May.

Abstract

Monoclonal antibody against the Mr 22,000 calcium-binding protein (sorcin) from an adriamycin-resistant myelogenous leukemia cell line K562 (K562/ADM) was prepared and used as a probe to study the localization of sorcin in K562/ADM cells and the parental cell line, K562. Analysis of extracts from K562/ADM cells by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorescence image analysis showed that K562/ADM cells possessed abundant sorcin in the cytoplasm which was almost entirely absent from the drug-sensitive parental cell line, K562. Furthermore, immuno-electron microscopic studies revealed that sorcin was closely associated with free ribosomes, rough endoplasmic reticulum, mitochondria, microfilament bundles and perinuclear membranes. These observations provide the first clue that the Ca-binding protein, sorcin, may play an important role in the development of the multidrug resistance phenomenon, although the relationship between sorcin and P-glycoprotein is still unknown.

PubMed Disclaimer

References

    1. ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Oh‐hara , T. , Hamada , H. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones . Jpn. J. Cancer Res. , 77 , 682 – 692 ( 1986. ). - PubMed
    1. ) Hamada , H. and Tsuruo , T.Functional role for the 170‐to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc, Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1987. ). - PMC - PubMed
    1. ) Pastan , I. and Gottesmann , M.Multiple‐drug resistance in human cancer . N. Engl. J. Med. , 316 , 1388 – 1393 ( 1987. ). - PubMed
    1. ) Sugawara , I. , Kataoka , I. , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multiple drug‐resistant gene as revealed by a monoclonal antibody, MRK 16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). - PubMed
    1. ) Sugawara , I. , Nakahara , M. , Hamada , H. , Tsuruo , T. and Mori , S.Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000–180,000 P‐glycoprotein . Cancer Res. , 48 , 4611 – 4614 ( 1988. ). - PubMed

MeSH terms

LinkOut - more resources